MAPP® – Instituto Português de Oncologia

01 January, 2020

Instituto Português de Oncologia do Porto has adopted our integrated solution, MAPP®, for increased safety on therapeutic administration and blood components.

This is an ongoing implementation project for both BTrac® and PharmaTrac®, which will result in 125 mobile devices with our MAPP® solution.

More News